Integration of biomarkers and imaging

Journal of Thoracic Oncology

Volumn 1, Issue 1, 2006, Pages 78-80

  Patz Jr , Edward F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Imaging; Molecular Diagnostics

Indexed keywords

CYTOKERATIN 19; MUCIN 1; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER GROWTH; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PATIENT CARE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; DIFFERENTIAL DIAGNOSIS; LUNG TUMOR; METABOLISM; METHODOLOGY; PROGNOSIS; RADIOGRAPHY; REVIEW; THORAX RADIOGRAPHY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG NEOPLASMS; PROGNOSIS; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 34247872897     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200601000-00016     Document Type: Conference Paper

References (7)

1. Aloia T, Bepler G, Harpole D, et al. Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities. Cancer Detect Prev 2001;25:336-343.
2. Manne U, Srivastava RG, Srivastava S. Recent advances in biomarkers for cancer diagnosis and treatment. Drug Discov Today 2006;10:965-976.
3. Campa MJ, Wang MZ, Howard B, Fitzgerald MC, Patz EF Jr. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res 2003;63:1652-1656.
4. Howard BA, Wang MZ, Campa MJ, Corro C, Fitzgerald MC, Patz EF Jr. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Proteomics 2003;3:1720-1724.
5. Howard BA, Zheng Z, Campa MJ, et al. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Lung Cancer 2004;46:313-323.
6. Suber RL, Flanders VL, Campa MJ, Patz EF Jr. Accentuation of differentially expressed proteins using phage technology. Anal Biochem 2004;333:351-357.
7. Khan N, Cromer CJ, Campa M, Patz EF Jr. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 2004;101:379-384.